-+ 0.00%
-+ 0.00%
-+ 0.00%

Milestone Pharma says China NMPA approves etripamil nasal spray for PSVT in adults

PUBT·09/03/2026 13:36:14
Listen to the news
Milestone Pharma says China NMPA approves etripamil nasal spray for PSVT in adults
  • Milestone Pharmaceuticals reported China’s NMPA cleared etripamil nasal spray for adult PSVT, its first approval outside the US.
  • Everest Medicines will commercialize the product in Greater China under an exclusive license.
  • The clearance triggers a USD 2 million milestone payment to Milestone; the deal includes up to USD 98 million in additional milestones.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Milestone Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030935PRIMZONEFULLFEED9821004) on September 03, 2026, and is solely responsible for the information contained therein.